Position in NTRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,180,690
-$85,431 QoQ
Shares Held
70,907
+13.9% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Catalio Capital Management, LP holds $24,212,931 across 2 Diagnostics & Research names. NTRA ranks #1 (58.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
This page
|
70,907 | $14,180,690 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
|
722,784 | $10,032,241 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,180,690 | 70,907 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,266,121 | 62,273 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,882,957 | 148,369 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,437,355 | 97,297 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||